Arthrodynamic Holdings, LLC
Records under this name other than the patents Arthrodynamic Holdings, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 10 of 10 · Back to Arthrodynamic Holdings, LLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,455,458 | Composition and method for treating connective tissue damage Term ended Term ended Oct 14, 2025 · USPTO record | Term ended | Term ended Oct 14, 2025 | USPTO record |
| US 9,186,375 | Glycosaminoglycan compositions in combination with stem cells Term ended Term ended Jul 12, 2024 · USPTO record | Term ended | Term ended Jul 12, 2024 | USPTO record |
| US 7,485,629 | Composition and method for treatment of joint damage Term ended Term ended Jun 1, 2024 · USPTO record | Term ended | Term ended Jun 1, 2024 | USPTO record |
| US 6,979,679 | Composition and method for treatment and prevention of traumatic synovitis and damage to articular cartilage Term ended Term ended May 11, 2024 · USPTO record | Term ended | Term ended May 11, 2024 | USPTO record |
| US 7,504,387 | Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis Term ended Term ended Apr 11, 2024 · USPTO record | Term ended | Term ended Apr 11, 2024 | USPTO record |
| US 8,580,766 | Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis Term ended Ended no later than Oct 16, 2023 · USPTO record | Term ended | Ended no later than Oct 16, 2023 | USPTO record |
| US 8,871,742 | Composition and method for treating connective tissue damage Term ended Ended no later than Oct 16, 2023 · USPTO record | Term ended | Ended no later than Oct 16, 2023 | USPTO record |
| US 9,937,209 | Glycosaminoglycan compositions in combination with stem cells Term ended Term ended Oct 16, 2023 · USPTO record | Term ended | Term ended Oct 16, 2023 | USPTO record |
| US 7,803,787 | Composition and method for treating connective tissue damage by transmucosal administration Lapsed on the fee record Ended Sep 28, 2022 · USPTO record | Lapsed on the fee record | Ended Sep 28, 2022 | USPTO record |
| US 9,381,211 | Composition and method for treating connective tissue damage Lapsed on the fee record Ended Jul 5, 2020 · USPTO record | Lapsed on the fee record | Ended Jul 5, 2020 | USPTO record |